Fierce Biotech August 9, 2024
Darren Incorvaia, Zoey Becker, Gabrielle Masson

Welcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren Incorvaia or Gabrielle Masson and it will be featured here at the end of each week.

Biogen CMO Maha Radhakrishnan joins Sofinnova

Sofinnova Investments

Former Biogen Chief Medical Officer Maha Radhakrishnan, M.D., is now an executive partner at healthcare investment firm Sofinnova Investments. Radhakrishnan previously held leadership roles at Sanofi, Bioverativ, Bristol Myers Squibb, UnitedHealth Group and Cephalon. At Sanofi, she led the medical strategy for diabetes and cardiovascular products and programs. Release

Flagship Pioneering taps White House vet Raj Panjabi in new role

Flagship Pioneering

Flagship Pioneering snagged...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article